Plunkett Research Online: UCB SA

UCB SA (UCBJY:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key pr.....



UCB SA
Ticker: UCBJY
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 32-2-559-99-99
Fax: 32-2-559-99-00
Address: Allee de la Recherche, 60
Brussels, B-1070 Belgium

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals Development
Industrial Chemical Products
Allergy & Respiratory Treatments
Central Nervous System Disorder Treatments
Contacts Description
Jean-Christophe TellierCEO/Director
Fiona du MonceauChairman of the Board/Director/Vice Chairman of the Board
See More
UCB is a Belgium-based biopharma firm focused on the development of novel therapies for the treatment of central nervous system and immunologic diseases. Historically, revenue was derived from allergy medicine Zyrtec and epilepsy drug Keppra, which have both lost patent protection. The firm's key pr.....See More See More

Auditor: PwC Reviseurs d'Entreprises sccrl
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Cimzia
Evenity
Briviact
Keppra
Vimpat
Neupro
Nayzilam
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: